pubmed-article:14501718 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:14501718 | lifeskim:mentions | umls-concept:C0138741 | lld:lifeskim |
pubmed-article:14501718 | lifeskim:mentions | umls-concept:C0618743 | lld:lifeskim |
pubmed-article:14501718 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
pubmed-article:14501718 | lifeskim:mentions | umls-concept:C0039593 | lld:lifeskim |
pubmed-article:14501718 | lifeskim:mentions | umls-concept:C1996904 | lld:lifeskim |
pubmed-article:14501718 | lifeskim:mentions | umls-concept:C0439810 | lld:lifeskim |
pubmed-article:14501718 | lifeskim:mentions | umls-concept:C1880497 | lld:lifeskim |
pubmed-article:14501718 | lifeskim:mentions | umls-concept:C0281186 | lld:lifeskim |
pubmed-article:14501718 | pubmed:issue | 4 Pt 1 | lld:pubmed |
pubmed-article:14501718 | pubmed:dateCreated | 2003-9-22 | lld:pubmed |
pubmed-article:14501718 | pubmed:abstractText | We investigated the value of serum measurements for glandular kallikrein 2 (hK2), and free (f) and total (t) prostate specific antigen (PSA) in a second round of biannual screening for prostate cancer. | lld:pubmed |
pubmed-article:14501718 | pubmed:language | eng | lld:pubmed |
pubmed-article:14501718 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14501718 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:14501718 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14501718 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14501718 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:14501718 | pubmed:month | Oct | lld:pubmed |
pubmed-article:14501718 | pubmed:issn | 0022-5347 | lld:pubmed |
pubmed-article:14501718 | pubmed:author | pubmed-author:HugossonJonas... | lld:pubmed |
pubmed-article:14501718 | pubmed:author | pubmed-author:LiljaHansH | lld:pubmed |
pubmed-article:14501718 | pubmed:author | pubmed-author:PetterssonKim... | lld:pubmed |
pubmed-article:14501718 | pubmed:author | pubmed-author:PiironenTimoT | lld:pubmed |
pubmed-article:14501718 | pubmed:author | pubmed-author:BeckerCharlot... | lld:pubmed |
pubmed-article:14501718 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:14501718 | pubmed:volume | 170 | lld:pubmed |
pubmed-article:14501718 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:14501718 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:14501718 | pubmed:pagination | 1169-74 | lld:pubmed |
pubmed-article:14501718 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:14501718 | pubmed:meshHeading | pubmed-meshheading:14501718... | lld:pubmed |
pubmed-article:14501718 | pubmed:meshHeading | pubmed-meshheading:14501718... | lld:pubmed |
pubmed-article:14501718 | pubmed:meshHeading | pubmed-meshheading:14501718... | lld:pubmed |
pubmed-article:14501718 | pubmed:meshHeading | pubmed-meshheading:14501718... | lld:pubmed |
pubmed-article:14501718 | pubmed:meshHeading | pubmed-meshheading:14501718... | lld:pubmed |
pubmed-article:14501718 | pubmed:meshHeading | pubmed-meshheading:14501718... | lld:pubmed |
pubmed-article:14501718 | pubmed:meshHeading | pubmed-meshheading:14501718... | lld:pubmed |
pubmed-article:14501718 | pubmed:meshHeading | pubmed-meshheading:14501718... | lld:pubmed |
pubmed-article:14501718 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:14501718 | pubmed:articleTitle | Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer. | lld:pubmed |
pubmed-article:14501718 | pubmed:affiliation | Department of Clinical Chemistry, Lund University, University Hospital Malmö, Sweden. charlotte.becker@klkemi.mas.lu.se | lld:pubmed |
pubmed-article:14501718 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:14501718 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14501718 | lld:pubmed |